Skip to content

Clinical trials

Phase 3 Schizophrenia trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Country / region: Poland Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20044
20051
20074
20083
20105
20114
20123
20134
20163
20175
20181
20191
20201
20214
20221
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Terminated7
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.7
H. Lundbeck A/S5
Janssen Research & Development, LLC4
Janssen-Cilag International NV4
ACADIA Pharmaceuticals Inc.3
AstraZeneca3
Boehringer Ingelheim3
FORUM Pharmaceuticals Inc3
Karuna Therapeutics, Inc., a Bristol Myers Squibb company3
Alkermes, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia47
Psychotic Disorders5
Cognition Disorders3
Autistic Disorder2
Bipolar Disorder1
Mania1
Recurrence1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.